ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,555.74
      -0.16%
      US Tech 100
      19,095.20
      -1.02%
      Dow Jones
      40,358.09
      -0.14%
      Brent Oil
      80.665
      -0.14%
      Bitcoin
      65,879.21
      -0.07%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. CytoMed Therapeutics Ltd (GDTC) Quote

      CytoMed Therapeutics Ltd

      CytoMed Therapeutics Ltd (GDTC)

      NASDAQ
      2.05
      -0.10
      (-4.65%)
      Closed July 24 4:00PM
      Delayed by 15 minutes
      2.00
      -0.05
      (-2.44%)
      After Hours: 6:48PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      2.00
      Bid
      1.96
      Ask
      2.20
      Volume
      58,049
      2.00 Day's Range 2.26
      1.88 52 Week Range 5.50
      Market Cap
      23.08M
      Previous Close
      2.15
      Open
      2.10
      Last Trade
      1000
      @
      2
      (formt)
      Last Trade Time
      Financial Volume
      $ 124,093
      VWAP
      2.1377
      Average Volume (3m)
      71,877
      Shares Outstanding
      11,540,000
      Dividend Yield
      -
      PE Ratio
      -5.72
      Earnings Per Share (EPS)
      -0.36
      Revenue
      518k
      Net Profit
      -4.13M

      About CytoMed Therapeutics Ltd

      CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing C... CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.cytomed.sg.
      Headquarters
      Singapore, Sgp
      Founded
      1970
      CytoMed Therapeutics Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GDTC. The last closing price for CytoMed Therapeutics was $2.15. Over the last year, CytoMed Therapeutics shares have traded in a share price range of $ 1.88 to $ 5.50.

      CytoMed Therapeutics currently has 11,540,000 shares outstanding. The market capitalization of CytoMed Therapeutics is $24.81 million. CytoMed Therapeutics has a price to earnings ratio (PE ratio) of -5.72.

      GDTC Latest News

      More News

      CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta (γδ) T Cells Technology for Solid and Liquid Cancers

      SINGAPORE, July 17, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its...

      July 17 2024
      GlobeNewswire Inc.

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      June 20 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      May 24 2024
      Edgar (US Regulatory)

      Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

      May 23 2024
      Edgar (US Regulatory)

      CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies

      SINGAPORE, March 18, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its...

      March 18 2024
      GlobeNewswire Inc.

      CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair

      SINGAPORE, March 04, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its...

      March 04 2024
      GlobeNewswire Inc.

      Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

      SINGAPORE, Jan. 29, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its...

      January 29 2024
      GlobeNewswire Inc.

      CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology

      CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology PR Newswire SINGAPORE, Dec. 5, 2023 SINGAPORE, Dec. 5, 2023 /PRNewswire/ -- CytoMed...

      December 05 2023
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10022.461.887621532.23828055CS
      4-0.06-2.912621359222.062.461.882129842.23720009CS
      12-0.07-3.381642512082.072.481.88718772.22981764CS
      26-2.04-50.4950495054.044.31.88455992.370299CS
      52-1.73-46.38069705093.735.51.88358333.11083817CS
      156-2-5049.251.881345094.55691902CS
      260-2-5049.251.881345094.55691902CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      DCAPUnity Wealth Partners Dynamic Capital Appreciation & Options ETF
       20.10
      (839.25%)
      		128.82k
      RGCRegencell Bioscience Holdings Ltd
      $ 15.15
      (349.55%)
      		1.34M
      ATPCAgape ATP Corporation
      $ 0.2262
      (58.18%)
      		107.32M
      SLRXSalarius Pharmaceuticals Inc
      $ 2.34
      (51.95%)
      		60.04M
      GSUNGolden Sun Health Technology Group Ltd
      $ 7.46
      (45.42%)
      		590.09k
      FLYEFly E Group Inc
      $ 1.1601
      (-81.82%)
      		25.44M
      RNAZTransCode Therapeutics Inc
      $ 0.3035
      (-61.70%)
      		9.78M
      JAGXJaguar Health Inc
      $ 1.755
      (-58.90%)
      		15.47M
      MIRAMIRA Pharmaceuticals Inc
      $ 2.55
      (-49.10%)
      		25.64M
      IVPInspire Veterinary Partners Inc
      $ 5.19
      (-43.83%)
      		1.67M
      SLNASelina Hospitality PLC
      $ 0.026
      (-29.73%)
      		220.33M
      SPWRSunPower Corporation
      $ 0.9514
      (32.91%)
      		186.76M
      NVDANVIDIA Corporation
      $ 122.59
      (-0.77%)
      		173.91M
      ADILAdial Pharmaceuticals Inc
      $ 1.3422
      (26.62%)
      		160.04M
      HOLOMicroCloud Hologram Inc
      $ 0.588
      (26.07%)
      		135.56M

      GDTC Discussion

      View Posts
      Monksdream Monksdream 3 days ago
      GDTC under $3
      👍️0
      glenn1919 glenn1919 7 days ago
      GDTC.............https://stockcharts.com/h-sc/ui?s=GDTC&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 3 months ago
      GDTC under $3
      👍️0
      Awl416 Awl416 6 months ago
      Halt
      👍️0
      Monksdream Monksdream 1 year ago
      GDTC gap fill candidate bears gotta love it
      👍️0
      Eurotradr Eurotradr 1 year ago
      So much further to go. $10 min.
      👍️0
      Monksdream Monksdream 1 year ago
      GDTC No 1 on the early Barchart Top 100
      https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
      👍️0
      AJ Freely AJ Freely 1 year ago
      $GDTC -Up 300% from yesterdays close
      A*STAR Spinoff CytoMed Therapeutics Announce a Patent for its Licensed CAR-Gamma Delta T Cell Technology Has Been Granted in the US
      Current Price $9.63
      👍️0
      Monksdream Monksdream 1 year ago
      Nurse Sherry bought 100 at $7.50
      👍️0

      Your Recent History

      NASDAQ
      GDTC
      CytoMed Therapeutics
      BITMOT
      2786315
      Belgium Fx 2.85% Oct34 Eur
      LSE
      58HS
      Gt.hall No1 Db
      TSX
      MINT.B
      Manulife Multifactor Dev...
      LSE
      GRPH
      LSE
      ARKK
      Ark Innovation
      Delayed Upgrade Clock